The Mounjaro Weightloss Pen
Mounjaro is an injectable medication available by prescription, intended for self-administration to aid in weight loss. It contains tirzepatide, a peptide that helps control blood sugar and energy, which in turn reduces hunger and cravings. By acting on specific brain signals, it enhances feelings of fullness, making it easier to feel satisfied and less likely to overeat. This mechanism helps curb the temptation to snack or indulge in unhealthy food choices. When paired with a healthy diet and consistent exercise, it can result in significant weight loss. Studies have shown that Mounjaro leads to more effective weight reduction than just diet and exercise alone, offering individuals additional support in their weight management journey. Its combination of appetite regulation and energy balance makes it a powerful tool for those struggling to lose weight.
Who is Mounjaro for?
It is intended for adults aged 18 to 74 who meet the following criteria:
- Prior Weight Management Attempts: Persons who have not attained substantial weight loss despite adherence to a supervised diet, behavioural modifications, and increased physical activity.
- Body Mass Index (BMI) Criteria:
– A BMI of 30 kg/m² or higher, or
– A BMI of 27 kg/m² or higher with at least one weight-related health condition, including:
- – Hypertension
- – Dyslipidemia (high cholesterol)
- – Obstructive sleep apnea
- – Type 2 diabetes
It is not recommended for persons with a history of pancreatitis, type 1 diabetes, or individuals under the age of 18, as its safety and efficacy have not been established in these populations.
Included in Your Order:
- – 1 x Mounjaro pen
- – 4 x Needles
- – 8 x Pre-injection wipes
Usage Instructions:
This is the 15mg dose, which is the recommended dose to increase after you have already used the 12.5mg dose. It is compatible with any Glucorx Finepoint or GlucoRx Carepoint needles, which are included in each order.
Ingredients:
Each 15 mg dose contains tirzepatide (15 mg in 0.6 mL solution), along with sodium phosphate dibasic heptahydrate, sodium chloride, concentrated hydrochloric acid, sodium hydroxide (for pH adjustment), and water for injection.
Administration Guidelines:
Prior to starting this treatment, carefully read the instructions for use (IFU) for proper administration details. It can be taken at any time of day, with or without food. You can inject it into the abdomen, thigh, or upper arm—be sure to switch injection sites with each dose. Always inspect the solution before use; it should be clear and colourless or have a slight yellow tint. Do not use the medication if the solution is discoloured or has particles in it.
Contraindications:
It is contraindicated in patients with:
- – A personal or family history of medullary thyroid carcinoma (MTC) or those with Multiple Endocrine Neoplasia syndrome type 2.
- – Known hypersensitivity to tirzepatide or any of its excipients.
Precautions and Warnings:
– Injection Site: Injection must be administered in the abdomen, thigh, or upper arm. The injection site and timing may vary without requiring dose adjustments.
– Missed Dose: If a dose is missed and it has been no longer than 4 days, administer the missed dose as soon as possible and proceed with the next scheduled dose. If more than 4 days have passed, skip the missed dose and continue with the regular dosing schedule.
– Change of Injection Day: The day for weekly administration can be adjusted, provided there is a minimum of 3 days between two doses. (≥72 hours).
– Storage: Store the medication in a refrigerator (2°C – 8°C). Do not freeze. Keep it in its original packaging to shield it from light. It may be stored at room temperature, not exceeding 30°C, for up to 21 cumulative days. After this period, the pre-filled pen must be discarded.
– Acute Pancreatitis Risk: Caution is advised for patients with a history of pancreatitis. Stop using it if symptoms of pancreatitis occur.
– Hypoglycemia Risk in Type 2 Diabetes: Monitor for hypoglycemia when using Mounjaro in combination with insulin or insulin secretagogues. Dose adjustments of insulin or other medications may be necessary.
– Gastrointestinal Disorders: For patients with severe gastrointestinal conditions, such as gastroparesis, use it with caution.
– Diabetic Retinopathy: Exercise caution in patients with diabetic retinopathy and ensure appropriate monitoring.
– Pregnancy and Lactation: Mounjaro is not recommended for use during pregnancy due to limited available data. It is also unknown whether the medication is excreted in human breast milk, so the potential risks should be weighed carefully against the benefits.
– Effects on Driving and Operating Machinery: It is unlikely to impair the ability to drive or operate machinery, but caution is advised when used with insulin or sulfonylurea to prevent hypoglycemia.
Adverse Effects: Potential side effects can include, but are not limited to:
- – Very Common: Hypersensitivity reactions, hypoglycemia (especially with insulin or sulfonylureas), and dizziness.
- – Common: Nausea, diarrhoea, vomiting, constipation, and fatigue.
- – Uncommon: Hair loss, abdominal pain, and acute pancreatitis.
For a complete list of potential side effects, please consult your healthcare provider.
How To Order?

Order your kit online and once it arrive collect your sample at home.

Then, drop off the Kit in the morning to the Royal Mail Red Street Box. Use the Track24/48 Return Label to the Lab.

Lastly, once your results are ready, we will send you an email with your Result. Also you can view the report in your Dashboard.
*Note:
- – (1) Dose-dependent
- – (2) More common in certain populations
- – Fatigue may encompass both general exhaustion and physical weakness.
Perry James –
I love the idea of adding my blood testing to my order.